Open company graph database — free web & API
Login

EP International Trade Co., Ltd.

EP国际贸易株式会社EP国際貿易株式会社AliasEPS Holdings, Inc.AliasEPSホールディングス株式会社Alias
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
7,932
Related companies
19
§01

Basic information

BASIC
Head office
2-1, Chikudo Hachiman-cho, Shinjuku-ku, Tokyo 162-0815, Chikudo Terrace, Japan
Chief executive
Hiroshi Gen
Capital
100,000,000
Employees (non-consolidated)
Employees (consolidated)
7,932 people
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

7
CRO businessSMO businessCSO businessYoshin businessSoken businessIncubation businessRelated business
§04

Related companies

19 COMPANIES
§05

Network

NETWORK
Drag to move · click to open
§06

History

20 EVENTS

Established EPS Tokyo Co., Ltd. with the purpose of developing and selling software related to clinical trials.Sources

Changed the company name to EPS Tokyo Co., Ltd.Sources

Started case registration and assignment services related to clinical trials and entered the CRO (Contract Research Organization) business.Sources

Contracted to develop support systems for two large-scale clinical trials of the Ministry of Health's pharmaceutical epidemiology research ('MEGA Study' and 'ATHEROMA Study'). Also started data center operations for both trials.Sources

Changed the company name to EPS Co., Ltd.Sources

Started operations in Shanghai as China's first full-fledged CRO.Sources

Started an SMO (Site Management Organization) business to support clinical trial-related activities at medical institutions.Sources

Started a CSO (Contract Sales Organization) business to handle MR activities for pharmaceutical companies.Sources

Changed the company name to EPS Co., Ltd.Sources

Listed shares on JASDAQ.Sources

Started CRO operations in Southeast Asia.Sources

Listed shares on the First Section of the Tokyo Stock Exchange.Sources

Started pharmaceutical sales operations in China.Sources

Transitioned to a holding company structure and changed its name to EPS Holdings Co., Ltd.Sources

Entered into a capital and business alliance agreement with Suzuken Co., Ltd.Sources

Participated in the joint development of a DNA vaccine for COVID-19.Sources

30th anniversary of founding.Sources

A new three-year medium-term management plan, 'SHINYO', has been launched.Sources

Completion of the company's building (Chikudo Terrace).Sources

EPNextS Co., Ltd., which oversees core businesses (CRO, SMO, CSO), has begun full operations.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑